We thank Drs Arno Bourgonje and Paola Mian1 for their interest in our study. We concur that infliximab clearance is not a fixed trait. In our study, we demonstrated that clearance is dynamic, being highest initially and gradually decreasing over time.
Gastroenterology (AGA) published a clinical update in Research Highlights on 23 Feb 2026.
The item focuses on Reply.
Review the original article for the full source wording and details.